Nissay Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39M | Buy |
|
|||||
|
2025
Q1 | $2.13M | Sell |
|
|||||
|
2024
Q4 | $3.17M | Buy |
|
|||||
|
2024
Q3 | $2.48M | Buy |
|
|||||
|
2024
Q2 | $2.18M | Buy |
|
|||||
|
2024
Q1 | $1.85M | Buy |
|
|||||
|
2023
Q4 | $1.35M | Buy |
|
|||||
|
2023
Q3 | $1.26M | Buy |
|
|||||
|
2023
Q2 | $897K | Sell |
|
|||||
|
2023
Q1 | $1.07M | Sell |
|
|||||
|
2022
Q4 | $1.14M | Sell |
|
|||||
|
2022
Q3 | $1.06M | Buy |
|
|||||
|
2022
Q2 | $950K | Sell |
|
|||||
|
2022
Q1 | $1.2M | Buy |
|
|||||
|
2021
Q4 | $1M | Buy |
|
|||||
|
2021
Q3 | $1.17M | Buy |
|
|||||
|
2021
Q2 | $1.15M | Sell |
|
|||||
|
2021
Q1 | $1.41M | Buy |
|
|||||
|
2020
Q4 | $1.16M | Buy |
|
|||||
|
2020
Q3 | $1.05M | Sell |
|
|||||
|
2020
Q2 | $1.82M | Sell |
|
|||||
|
2020
Q1 | $1.51M | Buy |
|
|||||
|
2019
Q4 | $976K | Buy |
|
|||||
|
2019
Q3 | $675K | Sell |
|
|||||
|
2019
Q2 | $1.51M | Buy |
|
|||||
|
2019
Q1 | $2.12M | Sell |
|
|||||
|
2018
Q4 | $2.21M | Buy |
|
|||||
|
2018
Q3 | $3M | Buy |
|
|||||
|
2018
Q2 | $2.96M | Buy |
|
|||||
|
2018
Q1 | $2.07M | Buy |
|
|||||
|
2017
Q4 | $1.46M | Buy |
|